| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OM | Common Stock | Options Exercise | $12.4K | +3.21K | +34.66% | $3.88* | 12.5K | Jan 3, 2022 | Direct | |
| transaction | OM | Common Stock | Sale | -$151K | -3.21K | -25.74% | $47.04 | 9.26K | Jan 3, 2022 | Direct | F1, F2 |
| transaction | OM | Common Stock | Options Exercise | $5.66K | +1.38K | +14.89% | $4.11 | 10.6K | Jan 3, 2022 | Direct | |
| transaction | OM | Common Stock | Sale | -$64.8K | -1.38K | -12.96% | $47.04 | 9.26K | Jan 3, 2022 | Direct | F1, F2 |
| transaction | OM | Common Stock | Options Exercise | $1.61K | +414 | +4.47% | $3.88* | 9.67K | Jan 3, 2022 | Direct | |
| transaction | OM | Common Stock | Sale | -$19.5K | -414 | -4.28% | $47.04 | 9.26K | Jan 3, 2022 | Direct | F1, F2 |
| transaction | OM | Common Stock | Options Exercise | $20.6K | +5K | +54.02% | $4.11 | 14.3K | Jan 3, 2022 | Direct | |
| transaction | OM | Common Stock | Sale | -$235K | -5K | -35.08% | $47.05 | 9.26K | Jan 3, 2022 | Direct | F1, F3 |
| transaction | OM | Common Stock | Options Exercise | $24.7K | +6K | +64.83% | $4.11 | 15.3K | Jan 3, 2022 | Direct | |
| transaction | OM | Common Stock | Sale | -$282K | -6K | -39.33% | $47.07 | 9.26K | Jan 3, 2022 | Direct | F1, F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OM | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -414 | -2.12% | $0.00 | 19.1K | Jan 3, 2022 | Common Stock | 414 | $3.88 | Direct | F5 |
| transaction | OM | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -1.38K | -5.18% | $0.00 | 25.2K | Jan 3, 2022 | Common Stock | 1.38K | $4.11 | Direct | F6 |
| transaction | OM | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -5K | -19.84% | $0.00 | 20.2K | Jan 3, 2022 | Common Stock | 5K | $4.11 | Direct | F6 |
| transaction | OM | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -6K | -29.7% | $0.00 | 14.2K | Jan 3, 2022 | Common Stock | 6K | $4.11 | Direct | F6 |
| transaction | OM | Performance Options (right to buy) | Options Exercise | $0 | -3.21K | -2.28% | $0.00 | 138K | Jan 3, 2022 | Common Stock | 3.21K | $3.88 | Direct | F7 |
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. |
| F2 | The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $45.00-$45.99 - 400 shares; $46.00-$46.99 - 854 shares; $47.00-$47.99 - 3,746 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $45.00-$45.99 - 400 shares; $46.00-$46.99 - 854 shares; $47.00-$47.99 - 3,546 shares; $48.00 - $48.99 - 200 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F4 | The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $45.00-$45.99 - 430 shares; $46.00-$46.99 - 964 shares; $47.00-$47.99 - 4,430 shares; $48.00 - $48.99 - 176 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F5 | This option vests 25% on October 9, 2018 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. |
| F6 | This option vests in 48 equal monthly installments beginning on December 3, 2018, subject to the reporting person's continued employment through the applicable vesting date. |
| F7 | This option vests if and to the extent that (1) the sum of (A) the 30-day closing price trading average of one share and (b) the aggregate amount of cash distributed with respect to one share (the "Aggregate Cash Distributions") is equal to or greater than $28.52 (reduced to $20.46) on any day following the expiration of the post-offering lock-up period or (11) the sum of (x) the value of all consideration that is distributable with respect to one Share in connection with a "Corporate Event" (as defined in the Outset Medical Amended and Restated 2010 Stock Incentive Plan (the "2010 Plan) and (Y) the Aggregate Cash Distribution is equal to or greater than $28.52 (reduced to $20.46 in 2020) as of the effective date of each Corporate Event. |